Elsevier

Acta Histochemica

Volume 119, Issue 3, April 2017, Pages 205-210
Acta Histochemica

Forkhead box-P3+ regulatory T cells and toll-like receptor 2 co-expression in oral squamous cell carcinoma

https://doi.org/10.1016/j.acthis.2016.12.005Get rights and content

Abstract

Background

The function of forkhead box-P3 (FoxP3) regulatory T cells (Treg) and toll-like receptor (TLR)2 protein in the oral cancer microenvironment is not fully understood, but evidence from other malignancies suggests it is likely they are involved with tumour development and progression. The aim of this study was to investigate the distribution of FoxP3+cells, TLR2+ cells and double-labelled FoxP3+TLR2+ immune cells in oral squamous cell carcinoma (OSCC), using immunohistochemistry (IHC) and immunofluorescence (IF).

Methods

25 archival cases of OSCC were immunostained with anti-FoxP3 and anti-TLR2 antibodies. Inflamed hyperplastic oral mucosal tissues were used as controls. The proportion of single-labelled, double-labelled and negative cells was determined.

Results

A higher frequency of double-labelled FoxP3+TLR2+ Tregs was observed within the immune cells of OSCC compared to inflamed controls using IHC (p < 0.05). Cell-to-cell contact between single-stained TLR2+ cells and FoxP3+ cells was noted. Double IF studies validated demonstration of co-expression of FoxP3+/TLR2+ immune cells in OSCC.

Conclusion

The presence of FoxP3+TLR2+ cells within the OSCC microenvironment may represent a dendritic cell-dependent pathway capable of inhibiting Treg suppressive activity, potentially enhancing the anti-tumour response. Modulation of TLR2-Treg interactions should be further explored to determine if they have a role in the therapeutic management of OSCC.

Introduction

Oral and oropharyngeal cancer is the sixth most common cancer in the world (Warnakulasuriya 2009). Oral squamous cell carcinoma (OSCC) is the most common form of oral and oropharyngeal cancer, with two-thirds of cases occurring in developing countries (Parkin et al., 2005).

The stroma of OSCC is almost always infiltrated by variable numbers of mononuclear immune cells, mostly lymphocytes, known as tumour infiltrating lymphocytes (TILs) (Rollins, 2006, Uppaluri et al., 2008). This phenomenon was initially thought to be evidence of an anti-tumour response (Yu and Fu, 2006), however functional analysis showed that the infiltrate was richly populated with CD4+ cells, with few NK cells (Snyderman et al., 1991). This population of CD4+ cells was later identified as forkhead box-P3 (FoxP3)+ regulatory T cells (Treg), which in normal circumstances, are important in maintaining immune homeostasis and preventing autoimmune diseases (Schwarz et al., 2008). Studies have shown expansion of this CD4+FoxP3+ Treg population in the tumour microenvironment (TME) of a range of cancers, including in OSCC, possibly induced by the local environment which is rich in interleukin (IL)10 and tumour growth factor (TGF)β (Bergmann et al., 2008, Watanabe et al., 2010, Lim et al., 2014). Malignant oral keratinocytes secrete TGFβ (Gasparoto et al., 2010), strongly indicating that OSCC cells are able to modulate the function of Tregs to their advantage.

For tumour antigens to induce an immunogenic effect, they have to be presented to antigen presenting cells (APCs). The antigen presentation mechanism is commonly chaperoned by a group of molecules belonging to the heat shock protein (HSP) family that interacts with transmembrane proteins such as the toll-like receptor (TLR) family. TLR2 recognises a wide variety of pathogen-associated molecular patterns (PAMPs) from exogenous pathogens, as well as endogenous damage-associated molecular patterns (DAMPs) including HSPs and high-mobility group box 1 protein (Sato et al., 2009). TLR2 expression on immune cells protected mice from developing colorectal cancer (Lowe et al., 2010) and mature dendritic cells (DC) injected with bacterial DNA were able to overcome immune tolerance in colon carcinoma (Heckelsmiller et al., 2002) using the TLR pathway. More keratinocytes in OSCC expressed TLR2 than keratinocytes in control epithelium (Ng et al., 2011). Whether or not this finding denotes the stimulation of an anti-tumour response or survival enhancement in OSCC is yet to be proven.

The expansion of the Treg population in OSCC is increasingly thought to be responsible for suppression of an anti-tumour response, which, in turn, facilitates cancer progression and leads to a poorer prognosis. TLRs, particularly TLR2, play a role in Treg expansion and facilitate their suppressive capacity (Sutmuller et al., 2006). On the other hand, TLR2 can induce loss of Treg function in a murine model with a shift to a pro-inflammatory (Th1) cytokine profile (Sutmuller et al., 2006). More recently it has been shown that TLR2 agonists induce tumour regression by modulating Treg and cytotoxic T cell (Tc) function (Zhang et al., 2011).

The ability of TLRs to modulate Treg and/or the TME has initiated interest in their potential role in cancer immunotherapy. It is not known whether activation of TLR2 receptors on Treg facilitates reversal of suppression of the anti-tumour response.

There are no reports describing the association of Tregs and TLR2 in the OSCC TME. The aim of this study was to investigate the presence and distribution of Tregs and TLR2+ cells in OSCC, as well as to correlate their distribution with the depth of tumour invasion.

Section snippets

Sample selection

The experiment was approved by University of Otago Institutional Ethics Committee (09/111). The database of the Medlab Dental Oral Pathology Diagnostic Service, Faculty of Dentistry, University of Otago was searched for specimens reported as primary OSCC. The original haematoxylin and eosin (H&E) slides were obtained to verify the diagnosis and confirm the suitability of the specimens using the following selection criteria: i) each section must contain a minimum of three regions with more than

IHC staining characteristics

Both OSCC and control groups showed strong intense immunostaining of both single-stained and double-stained positive cells with minimal background in all sections. Single-stained FoxP3+ cells showed intense brown nuclear staining (Fig. 1A) compared with isotype-matched control (Fig. 1B), whereas TLR2+ cells (stained with Fast Red) showed a dusky red ring around the cell membrane with granular cytoplasmic staining (Fig. 1C) compared with isotype-matched control (Fig. 1D). Double-stained FoxP3+

Discussion

TLRs and TLR signalling plays an important role in regulating innate and adaptive immune responses as well as regulating immune responses during carcinogenesis. Their normal biological role is widely recognised as an early protective mechanism against invading pathogens, however their exact function in carcinogenesis remains unclear. TLRs have been implicated in carcinogenesis most particularly in organs constantly exposed to bacteria such as skin, gastric, liver and colorectal cancer (Tye and

Conclusion

In summary, the presence of double-stained FoxP3+TLR2+ cells within the OSCC TME was observed with apparent cell-to-cell contact between TLR2+ and FoxP3+ cells. The presence of FoxP3+TLR2+ cells may represent a DC-dependent pathway capable of inhibiting Treg suppressive activity. This finding may be beneficial to the anti-tumour response; modulation of TLR2-Treg interactions should be explored via assessment of cytokines in the TME. This may hold the key to shifting the balance into triggering

Acknowledgements

The authors would like to thank the New Zealand Dental Association for financial support of this research work. The authors would also like to thank the staff of Oral Pathology Services, University of Otago, Ms Lynda Horne and Mrs Sharla Kennedy for their support and assistance in this research.

References (36)

  • T.H. Gasparoto et al.

    Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment

    Cancer Immunol. Immunother.

    (2010)
  • M. Guha

    Anticancer TLR agonists on the ropes

    Nat. Rev. Drug Discov.

    (2012)
  • K. Heckelsmiller et al.

    Peritumoral CpG DNA elicits a coordinated response of CD8T cells and innate effectors to cure established tumors in a murine colon carcinoma model

    J. Immunol.

    (2002)
  • S.D. Killeen et al.

    Exploitation of the toll-like receptor system in cancer: a doubled-edged sword?

    Br. J. Cancer

    (2006)
  • K.P. Lim et al.

    CD4+CD25hiCD127low regulatory T cells are increased in oral squamous cell carcinoma patients

    PLoS One

    (2014)
  • E.L. Lowe et al.

    Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer

    PLoS One

    (2010)
  • L.K. Makinen et al.

    Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas

    J. Oral Pathol. Med.

    (2016)
  • A. Mantovani et al.

    Cancer-related inflammation

    Nature

    (2008)
  • Cited by (13)

    • Biological implications of the immune factors in the tumour microenvironment of oral cancer

      2022, Archives of Oral Biology
      Citation Excerpt :

      The toll-like receptor 2 (TLR2), a transmembrane protein that mediates the antigen presentation by the antigen-presenting cells, is co-expressed with FoxP3 in an OSCC microenvironment. The FoxP3 + TLR2+ cells within the OSCC microenvironment may be capable of inhibiting the Treg suppressive function, thereby promoting antitumour immunity (Hussaini, Parachuru, Seymour, & Rich, 2017). Macrophages are functional derivatives of the haematopoietic stem cell lineage which phagocytose cellular debris and foreign particles.

    • In HPV-negative oropharyngeal squamous cell carcinoma, elevated toll-like receptor 2 immunoexpression may increase the risk of disease-specific mortality

      2020, Oral Oncology
      Citation Excerpt :

      TLRs expressed in the immune cells contribute to chronic inflammation and an to attacking of tumor cells, whereas TLRs expressed during carcinogenesis by tumor cells may promote cancer-cell survival and chemoresistance [16,17]. The role of TLRs is, however, controversial, since TLR-activated immune cells may also show pro-tumorigenic effects [18,19]. The expression of TLRs may be prognostic in several cancers including colorectal-, salivary gland-, and non-small cell lung cancer, and squamous cell carcinoma of the tongue [20–24].

    View all citing articles on Scopus
    View full text